Year: 2015
Type: Article
Title: Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
Author: Krstevska balkanov, Svetlana
Author: Genadieva Stavrikj, Sonja
Author: Cevrevska, Lidija
Author: Georgjievski, Borce
Author: Karanfilski, Oliver
Author: Sotirova, Tatjana
Author: Balkanov, Trajan
Abstract: Bone lytic lesion in Multiple myeloma are the most commonly presented symptoms which require treatment with bisphosphonates (BPs). BPs are providing supportive care, reducing the rate of skeletal morbidity but evidently not abolishing it, the criteria for stopping their administration have to be different from those used for classic antineoplastic drugs, and they should not be stopped when metastatic bone disease is progressing. Osteonecrosis of the jaw (ONJ) has been associated recently with the use of BPs.
Publisher: ScopeMed
Relation: Medical archives (Sarajevo, Bosnia and Herzegovina)
Identifier: oai:repository.ukim.mk:20.500.12188/26527
Identifier: 0350-199X
Identifier: http://hdl.handle.net/20.500.12188/26527Identifier: http://www.scopemed.org/fulltextpdf.php?mno=209586Identifier: 69
Identifier: 6
